# FDA Inspection 1165963 - Spectrum Pharmaceuticals, Inc. - March 04, 2022

Source: https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/eda95d2e-8f21-45a3-b878-8e194e9439e2
Source feed: FDA_Inspections

> FDA Inspection 1165963 for Spectrum Pharmaceuticals, Inc. on March 04, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165963
- Company Name: Spectrum Pharmaceuticals, Inc.
- Inspection Date: 2022-03-04
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1117779 - 2020-02-12](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/fdef18b8-7dd0-44fc-abef-2f0a1fa7279d)
- [FDA Inspection 1006382 - 2017-03-15](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/73052981-d8ac-416b-a141-b2a4fb4769f7)
- [FDA Inspection 973856 - 2016-05-27](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/c4bfdb12-55a3-41bd-b948-d1b51cf25a73)
- [FDA Inspection 924451 - 2015-03-31](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/e268a4f2-b436-473f-b7d7-e936f95d2348)
- [FDA Inspection 924451 - 2015-03-31](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/22da3cb7-315a-4736-8e21-fb71b54db200)

Company: https://www.keypedia.com/companies/spectrum-pharmaceuticals-inc/d2be8240-3764-497f-8d0d-fbedb45f3053

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c